Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?STRIFE, A; CLARKSON, B.Seminars in hematology. 1988, Vol 25, Num 1, pp 1-19, issn 0037-1963Article

CELL KILL KINETICS WITH HYDROXYUREA.YATAGANAS X; STRIFE A; PEREZ A et al.1976; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1976; VOL. 2; NO 1; PP. 39-54; BIBL. 1 P. 1/2Article

THE KINETIC SIGNIFICANCE OF CEL SIZE. I. VARIATION OF CELL CYCLE PARAMETERS WITH SIZE MEASURED AT MITOSIS = IMPORTANCE CINETIQUE DU VOLUME DES CELLULES. I. VARIATION DES PARAMETRES DU CYCLE CELLULAIRE AVEC LE VOLUME MESURE A LA MITOSEYEN A; FRIED J; KITAHARA T et al.1975; EXPER. CELL RES.; U.S.A.; DA. 1975; VOL. 95; NO 2; PP. 295-302; BIBL. 15 REF.Article

MICROFLUORIMETRIC EVALUATION OF CELL KILL KINETICS WITH 1-BETA -D-ARABINOFURANOSYLCYTOSINEYATAGANAS X; STRIFE A; PEREZ A et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 10; PP. 2795-2806; BIBL. 1 P. 1/2Article

SUBPOPULATIONS OF HUMAN PERIPHERAL BLOOD CELLS: ANALYSIS OF GRANULOCYTIC PROGENITOR CELLS BY FLOW CYTOMETRY AND IMMUNOLOGIC SURFACE MARKERSDRAPKIN RL; ADREEFF M; KOZINER B et al.1979; AMER. J. HEMATOL.; USA; DA. 1979; VOL. 7; NO 2; PP. 163-172; BIBL. 25 REF.Article

GROWTH CHARACTERISTICS OF LEUKEMIC AND NORMAL HEMATOPOIETIC CELLS IN PH'+CHRONIC MYELOGENOUS LEUKEMIA AND EFFECTS OF INTENSIVE TREATMENTGOTO T; NISHIKORI M; ARLIN Z et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 4; PP. 793-808; BIBL. 60 REF.Article

EFFECTS OF THYMIDINE AND THYMIDINE PLUS 5-FLUOROURACIL ON THE GROWTH KINETICS OF A HUMAN LYMPHOID CELL LINEMURGO AJ; FRIED J; BURCHENAL D et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 5; PP. 1543-1549; BIBL. 30 REF.Article

DURATION OF THE DORMANT STATE IN AN ESTABLISHED CELL LINE OF HUMAN HEMATOPOIETIC CELLS.CLARKSON BD; FRIED J; TING CHAO CHOU et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 12; PP. 4506-4522; BIBL. 2 P.Article

COMPUTER ANALYSIS OF TRACER KINETIC DATA FROM A HUMAN HEMATOPOIETIC CELL LINE DURING DIFFERENT PHASES OF GROWTHFRIED J; FRIEDMAN H; ZIETZ S et al.1974; COMPUTERS BIOMED. RES.; U.S.A.; DA. 1974; VOL. 7; NO 4; PP. 333-359; BIBL. 18REF.Article

Co-detection of chimeric BCR/ABL (target) and β-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reactionWISNIEWSKI, D; STRIFE, A; CLARKSON, B et al.Leukemia research. 1991, Vol 15, Num 9, pp 867-874, issn 0145-2126Article

c-kit ligand stimulates tyrosine phosphorylation a similar pattern of phosphotyrosyl proteins in primary primitive normal hemtopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemiaWISNIEWSKI, D; STRIFE, A; BERMAN, E et al.Leukemia. 1996, Vol 10, Num 2, pp 229-237, issn 0887-6924Article

Photoradiation models for the clinical ex vivo treatment of autologous bone marrow graftsATZPODIEN, J; GULATI, S. C; STRIFE, A et al.Blood. 1987, Vol 70, Num 2, pp 484-489, issn 0006-4971Article

Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligandSTRIFE, A; PEREZ, A; LAMBEK, C et al.Cancer research (Baltimore). 1993, Vol 53, Num 2, pp 401-409, issn 0008-5472Article

Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients = Potentiel prolifératif des sous-populations de cellules-souches de granulocytes-macrophages chez les sujets normaux et chez les malades atteints de leucémie myéloïde chroniqueSTRIFE, A; LAMBEK, C; WISNIEWSKI, D et al.Blood. 1983, Vol 62, Num 2, pp 389-397, issn 0006-4971Article

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategiesCLARKSON, B; STRIFE, A; WISNIEWSKI, D et al.Leukemia. 2003, Vol 17, Num 7, pp 1211-1262, issn 0887-6924, 52 p.Article

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210^BCR-ABLBERMAN, E; JHANWAR, S; MCBRIDE, M et al.Leukemia research. 2000, Vol 24, Num 4, pp 289-297, issn 0145-2126Article

TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitroLEMOLI, R. M; STRIFE, A; CLARKSON, B. D et al.Experimental hematology. 1992, Vol 20, Num 11, pp 1252-1256, issn 0301-472XArticle

A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populationsWISNIEWSKI, D; STRIFE, A; WOJCIECHOWICZ, D et al.Leukemia. 1994, Vol 8, Num 4, pp 688-693, issn 0887-6924Conference Paper

Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligandSTRIFE, A; PEREZ, A; LAMBEK, C et al.Leukemia research. 1993, Vol 17, Num 9, pp 799-807, issn 0145-2126Article

Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags in enhanced by colony-stimulating factorsLEMOLI, R. M; TAFURI, A; STRIFE, A et al.Experimental hematology. 1992, Vol 20, Num 5, pp 569-575, issn 0301-472XArticle

Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factor IL-3, GM-CSF and G-CSF alone and in combinationLEMOLI, R. M; GULATI, S. C; STRIFE, A et al.Leukemia. 1991, Vol 5, Num 5, pp 386-391, issn 0887-6924Article

A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) Is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cellsWISNIEWSKI, D; STRIFE, A; SWENDEMAN, S et al.Blood. 1999, Vol 93, Num 8, pp 2707-2720, issn 0006-4971Article

Monoclonal antibody YB5.B8 identifies the human c-kit protein productLERNER, N. B; NOCKA, K. H; COLE, S. R et al.Blood. 1991, Vol 77, Num 9, pp 1876-1883, issn 0006-4971Article

The effects of transforming growth factor β₃ on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral bloodSTRIFE, A; LAMBEK, C; PEREZ, A et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4828-4836, issn 0008-5472Conference Paper

Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeadsSHIMAZAKI, C; WISNIEWSKI, D; SCHEINBERG, D. A et al.Blood. 1988, Vol 72, Num 4, pp 1248-1254, issn 0006-4971Article